Saturday, July 6, 2019
17:00 – 17:30
Beverley Hunt (United Kingdom)
Topic: Postpartum Hemorrhage

Sunday, July 7, 2019
09:30 – 10:15
Joe Italiano (USA)
​Topic: Molecular Drivers of Platelet Production

Monday, July 8, 2019
09:30 -10:15
Marie Scully (United Kingdom)
Topic: Thrombotic Microangiopathies

Tuesday, July 9, 2019
09:30 – 10:15
Thomas Renné (Germany)
​Topic: Safe Anticoagulants: Targeting the Contact Pathway

Learn more about the plenary speakers:

Beverley Hunt
United Kingdom
King’s College London

Beverley Hunt is a Professor of Thrombosis & Haemostasis at King’s College London. She is also a Consultant in the Departments of Haematology & Pathology at Guy’s & St Thomas NHS Foundation Trust; & Clinical Lead in Haematological Sciences at Viapath LLP.

Hunt has a large clinical practice, specializing in thrombosis and hemostasis & obstetric hematology. She leads on the management of thrombosis within GSTT. She set up the award-winning “Thrombosis” app – thrombosis management in elegant algorithms. She also runs a research group with over 330 peer-reviewed publications to her name, and won the BMJ Research paper of the year 2011 with the CRASH-2 team. Hunt sits on the editorial boards of the British Journal for HaematologyJournal of Thrombosis & HaemostasisLupusand Seminars in Thrombosis & Haemostasis.

She is a co-chair of the ISTH 2022 Congress in London and is a co-chair of the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis.

She founded and is now Medical Director of the thrombosis charity, ‘Lifeblood: the thrombosis charity’, which re-branded as Thrombosis UK. And she is a founding steering committee member of World Thrombosis Day. 



Marie Scully
United Kingdom
University College London

Professor Marie Scully is a Consultant Haematologist at UCLH and Professor of Thrombosis and Haemostasis, UCL, London, UK with an interest in hemostasis and thrombosis. She has a particular interest in platelet mediated disorders, specifically, ITP, TTP and TMAs. 

Primary publications include TTP, in particular treatment and clinical subtypes, in conjunction with an understanding of the pathogenesis of their underlying disease. She holds grants with the Medical Research Unit and the British Heart Foundation, Baxalta and Shire. 

She supervises post graduate trainees undertaking either M.D. or Ph.D. She is clinical lead for the UK TTP forum and European Hematology Association Thrombotic Microangiopathy Subgroup. She has published in peer review journals and is a reviewer for high impact hematology, hemostasis and thrombosis, and general medical journals.

Joe Italiano
Harvard Medical School

Joseph E. Italiano Jr. is Associate Professor of Medicine at Brigham and Women’s Hospital, USA and Harvard Medical School, Boston, USA. He is also an Assistant Professor of Medicine in the Department of Surgery at Boston Children’s Hospital. Italiano received his bachelor of science degree from The College of New Jersey, USA, in 1992. He received his doctoral degree from Florida State University, USA, in cell biology. After completing postdoctoral training in hematology at Brigham and Women’s Hospital, he joined the faculty at Harvard Medical School.

​He is the recipient of a number of NIH grants. His awards and honors include the American Society of Hematology Scholar Award and American Heart Foundation Scientist Development Grant.

Italiano’s scientific interests have long focused on megakaryocyte and platelet biology. His early research focused on using live cell microscopy to identify the basic principles of platelet production. In particular, his efforts have contributed to improved understanding of the biochemical and molecular mechanisms underlying platelet biogenesis. More recently, his research efforts have focused on understanding the non-hemostatic roles of platelets under physiological and pathological conditions.



Thomas Renné
University Medical Center Hamburg

Thomas Renné is Professor of Clinical Chemistry and Director of the Institute for Clinical Chemistry and Laboratory Medicine at the University Medical Center Hamburg, Germany. He was trained in Medicine and Chemistry and completed his Ph.D. in 1999 at the Johannes Gutenberg University in Mainz, Germany. 

Renné finished his fellowship in Laboratory Medicine and started his own research group at Würzburg University, Germany. Before moving to Hamburg he worked at the Karolinska Institute, Sweden. His research interest is the factor XII-driven plasma contact system at the nexus of coagulation and inflammation. The Renné lab is exploring contact system activators and the therapeutic potential of targeting the contact system for safe anti-anticoagulation strategies that exert additional anti-inflammatory activities.

Share this story, choose your platform!